Company · CIK 1560241
G1 Therapeutics, Inc.
| CIK | 1560241 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NC |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2017-08-09 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-257640 | 2021-07-02 | 2022-11-21 | 4 | |
| 333-225678 | 2018-06-15 | 2018-09-19 | 3 | |
| 333-223445 | 2018-03-05 | 2018-03-08 | 3 | |
| 333-217285 | 2017-04-13 | 2017-05-17 | 6 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2022-11-21 | 424B5Shelf takedown | 333-257640 | 0001193125-22-289241 |
| 2022-11-17 | 424B5Shelf takedown | 333-257640 | 0001193125-22-287652 |
| 2022-05-03 | EFFECTDeclared effective | 333-257640 | 9999999995-22-001275 |
| 2021-07-02 | S-3ASRShelf registered | 333-257640 | 0001193125-21-207590 |
| 2018-09-19 | 424B5Shelf takedown | 333-225678 | 0001193125-18-277677 |
| 2018-09-17 | 424B5Shelf takedown | 333-225678 | 0001193125-18-275435 |
| 2018-06-15 | S-3ASRShelf registered | 333-225678 | 0001193125-18-194624 |
| 2018-03-08 | 424B4Final prospectus | 333-223445 | 0001193125-18-075324 |
| 2018-03-07 | EFFECTDeclared effective | 333-223445 | 9999999995-18-000553 |
| 2018-03-05 | S-1Registration filed | 333-223445 | 0001193125-18-070501 |
| 2018-02-23 | DRSDraft made public | 377-01949 | 0000950123-18-002690 |
| 2017-05-17 | 424B4Final prospectus | 333-217285 | 0001193125-17-173866 |
| 2017-05-16 | EFFECTDeclared effective | 333-217285 | 9999999995-17-001306 |
| 2017-05-11 | S-1/AAmendment | 333-217285 | 0001193125-17-167419 |
| 2017-05-08 | S-1/AAmendment | 333-217285 | 0001193125-17-161834 |
| 2017-04-27 | S-1/AAmendment | 333-217285 | 0001193125-17-139969 |
| 2017-04-13 | S-1Registration filed | 333-217285 | 0001193125-17-123000 |
| 2016-02-05 | DRSDraft made public | 377-01260 | 0000950123-16-013508 |